Rchr
J-GLOBAL ID:200901076740954215   Update date: Nov. 02, 2024

Hotta Katsuyuki

ホッタ カツユキ | Hotta Katsuyuki
Affiliation and department:
Research theme for competitive and other funds  (6):
  • 2020 - 2024 Quality management of Advanced medical care clinical resarch under Clinical Trial Act for pharmaceutial approval application
  • 2020 - 2023 EGFR肺癌における第3世代EGFR-TKI耐性へのIL-6の関与と克服の検討
  • 2018 - 2021 Preemptive Medicine to Solid Tumors based on Epigenomics
  • 2014 - 2018 Potential influence of interleukin-6 on the therapeutic effect of gefitinib in patients with advanced non-small cell lung cancer harbouring EGFR mutations
  • 2011 - 2015 Basic and clinical study of EGFR gene mutation-positive lung cancer using a genetically modified mouse
Show all
Papers (188):
  • Taichi Ozeki, Hisao Higo, Hiroki Omori, Shunta Mori, Shin Tanaka, Go Makimoto, Kiichiro Ninomiya, Akihiko Taniguchi, Masanori Fujii, Kentaro Miyoshi, et al. A Case of Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension. Internal medicine (Tokyo, Japan). 2024
  • Naoki Nakamura, Go Makimoto, Takaaki Tanaka, Yuka Kato, Isao Oze, Toshiyuki Kozuki, Toshihide Yokoyama, Hirohisa Ichikawa, Shoichi Kuyama, Naofumi Hara, et al. A randomized, open-label phase II study on the preventive effect of goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: The OLCSG2101 study protocol. Respiratory investigation. 2024. 62. 5. 897-900
  • Hiroaki Matsuura, Hisao Higo, Tadahiro Kuribayashi, Akihiko Tamaoki, Takamasa Nakasuka, Mari Uno, Go Makimoto, Kiichiro Ninomiya, Masanori Fujii, Kammei Rai, et al. Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR-mutated lung cancer and pulmonary tuberculosis: A case report. Thoracic cancer. 2024. 15. 17. 1390-1394
  • Tadahiro Kuribayashi, Kadoaki Ohashi, Kazuya Nishii, Kiichiro Ninomiya, Yukari Tsubata, Nobuhisa Ishikawa, Masahiro Kodani, Nobuhiro Kanaji, Masahiro Yamasaki, Kazunori Fujitaka, et al. Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study. Journal of cancer research and clinical oncology. 2024. 150. 2. 89-89
  • Masahiro Yamashita, Hisao Higo, Nobuharu Fujii, Chiaki Matsumoto, Go Makimoto, Kiichiro Ninomiya, Masanori Fujii, Kammei Rai, Eiki Ichihara, Kadoaki Ohashi, et al. Protracted coronavirus disease 2019 after chimeric antigen receptor-T cell therapy successfully treated with sequential multidrug therapy. Respiratory medicine case reports. 2024. 51. 102104-102104
more...
MISC (166):
  • 藤岡 佑輔, 田岡 征高, 槇本 剛, 栗林 忠弘, 松浦 宏昌, 下西 惇, 二宮 貴一朗, 肥後 寿夫, 久保 寿夫, 大橋 圭明, et al. 大量喀血に対して気管支動脈塞栓術と気管支充填術が奏効したALK陽性肺癌の1例. 気管支学. 2022. 44. Suppl. S307-S307
  • 久保 寿夫, 二宮 貴一朗, 槇本 剛, 加藤 有加, 藤井 昌学, 市原 英基, 大橋 圭明, 堀田 勝幸, 田端 雅弘, 前田 嘉信, et al. がん遺伝子パネル検査を行った胸腺がん5例の検討. 日本呼吸器学会誌. 2022. 11. 増刊. 279-279
  • 宮本 真志, 松浦 宏昌, 市原 英基, 大橋 圭明, 堀田 勝幸, 木浦 勝行, 久保 寿夫, 田端 雅弘, 寺石 文則, 前田 嘉信. 肺癌と直腸癌の重複癌に対してペムブロリズマブが長期に奏効した1例. 肺癌. 2021. 61. 7. 1006-1006
  • 西村 智香, 大橋 圭明, 大川 祥, 太田 萌子, 平生 敦子, 市原 英基, 木浦 勝行, 久保 寿夫, 田端 雅弘, 堀田 勝幸. Foundation one CDxにて診断されたMET増幅肺癌に対しクリゾチニブが著効した1例. 肺癌. 2021. 61. 7. 1011-1012
  • Nobuaki Ochi, Eiki Ichihara, Nagio Takigawa, Daijiro Harada, Koji Inoue, Takuo Shibayama, Shinobu Hosokawa, Daizo Kishino, Shingo Harita, Naohiro Oda, et al. Response to letter re: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression. European journal of cancer (Oxford, England : 1990). 2021. 157. 523-524
more...
Lectures and oral presentations  (1):
  • 肺癌診療ガイドライン改訂のポイント ー薬物療法の領域を中心にー
    (2023)
Professional career (1):
  • 医学博士 (岡山大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page